These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 15767330

  • 1. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
    Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, Christiani DC.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
    [Abstract] [Full Text] [Related]

  • 2. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y, Spitz MR, Lei L, Mills GB, Wu X.
    Cancer Res; 2001 Nov 01; 61(21):7825-9. PubMed ID: 11691799
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.
    Carcinogenesis; 2004 Dec 01; 25(12):2379-84. PubMed ID: 15319295
    [Abstract] [Full Text] [Related]

  • 5. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V.
    BJU Int; 2008 Feb 01; 101(4):503-7. PubMed ID: 17986285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
    Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L.
    Mutagenesis; 2010 Jan 01; 25(1):41-8. PubMed ID: 19843588
    [Abstract] [Full Text] [Related]

  • 8. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep 01; 40(9):601-4. PubMed ID: 16202315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
    Li Y, Wang Y, Kang S, Zhang JH, Guo W, Wang N, Jin X, Fang SM.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul 01; 40(7):472-5. PubMed ID: 16080875
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L, Zhang J.
    Carcinogenesis; 2005 Feb 01; 26(2):481-6. PubMed ID: 15528217
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH.
    Ai Zheng; 2005 Mar 01; 24(3):305-10. PubMed ID: 15757531
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Blasiak J.
    Breast Cancer Res Treat; 2006 Jan 01; 95(1):65-72. PubMed ID: 16267613
    [Abstract] [Full Text] [Related]

  • 15. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS, Lee SJ, Choi JE, Cha SI, Lee EB, Park TI, Kim CH, Lee WK, Kam S, Choi JY, Kang YM, Park RW, Kim IS, Cho YL, Jung TH, Han SB, Park JY.
    Cancer Epidemiol Biomarkers Prev; 2005 Nov 01; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
    Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, Scorza R.
    Clin Cancer Res; 2001 Aug 01; 7(8):2344-6. PubMed ID: 11489811
    [Abstract] [Full Text] [Related]

  • 17. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
    Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, Nkenke E, Ragos V, Vylliotis A, Spyridonidou S, Tsigris C, Yannopoulos A, Tesseromatis C, Neukam FW, Patsouris E.
    Anticancer Res; 2007 Aug 01; 27(1A):459-64. PubMed ID: 17352267
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I.
    Coron Artery Dis; 2009 Sep 01; 20(6):383-6. PubMed ID: 19620856
    [Abstract] [Full Text] [Related]

  • 19. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R.
    Clin Cancer Res; 2002 Dec 01; 8(12):3820-3. PubMed ID: 12473595
    [Abstract] [Full Text] [Related]

  • 20. DHPLC analysis of the matrix metalloproteinase-1 promoter 1G/2G polymorphism that can be easily used to screen large population.
    Xu E, Lai M, Lv B, Xing X, Huang Q, Ma Y, Wang W.
    J Biochem Biophys Methods; 2005 Jun 30; 63(3):222-7. PubMed ID: 15939478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.